Willem H. van Harten

prof.dr.

  • 2513 Citations
  • 24 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Meeting Abstract
2019
1 Citation (Scopus)
1 Downloads (Pure)
2018

MammaPrint is cost-effective compared to clinical risk assessment in early stage breast cancer

Retèl, V. P., van ‘t Veer, L. J., Cardoso, F., Piccart, M. J., Rutgers, E. J. T., Tryfonidis, K., Poncet, C. & van Harten, W. H., 2018, In : Cancer research. 78, 4S

Research output: Contribution to journalMeeting AbstractAcademic

2017

A general model for cancer centers to conduct health technology assessments: a practical case of next generation sequencing in oncology

Retel, V., Mewes, J., Wind, A., Rocha-Goncalves, F. N. & van Harten, W. H., 7 Feb 2017, In : European journal of cancer. 72, 1, p. S118 1030.

Research output: Contribution to journalMeeting AbstractAcademic

1 Downloads (Pure)

Cost-effectiveness and feasibility of implementing mri-guided neoadjuvant chemotherapy to treat er-positive her2-negative breast cancers in the Netherlands

Miquel-Cases, A., Steuten, L. & van Harten, W. H., Nov 2017, In : Value in health. 18, 7, p. A463-A463 PCN186.

Research output: Contribution to journalMeeting AbstractAcademic

Open Access
File
40 Downloads (Pure)

Evaluation of early implementation of tumor-infiltrating lymphocytes in treating advanced melanoma in an academic setting: a constructive technology analysis

Lindenberg, M. A., Retèl, V. P., Foppen, M. H. G., van den Berg, J., Haanen, J. & van Harten, W. H., 29 Jan 2017, In : European journal of cancer. 72, S1, p. S130-S131 1263.

Research output: Contribution to journalMeeting AbstractAcademic

2016

Development of a benchmark tool for comprehensive cancer centers: results from a pilot exercise

Wind, A., van Lent, W. A. M., Nagy, P. & van Harten, W. H., 2016, In : Journal of clinical oncology. 34, 15S, e18159.

Research output: Contribution to journalMeeting AbstractAcademic

Piloting a generic cancer consumer quality index for cancer patients in European countries

Wind, A., Heerink, J., Sixma, H., Presti, P., Lombardo, C. & van Harten, W. H., 2016, In : Journal of clinical oncology. 34, 15S, e18163.

Research output: Contribution to journalMeeting AbstractAcademic

2015

H-TArget model: Early technology assessment for ext generation sequencing in oncology

Retèl, V., Joore, M. A., Ramaekers, B., van den Heuvel, M. M., van der Heijden, M. S. & van Harten, W. H., 2015, In : Journal of clinical oncology. 33, 15, suppl., 1 p., 6604.

Research output: Contribution to journalMeeting AbstractOther research output

Open Access
File
50 Downloads (Pure)

Value Of Implementation Of Physical Exercise For Cancer Survivors

Mewes, J., Steuten, L., IJzerman, M. J. & van Harten, W. H., Nov 2015, In : Value in health. 18, 7, PA456.

Research output: Contribution to journalMeeting AbstractAcademic

Open Access
45 Downloads (Pure)
2014
41 Downloads (Pure)

Effect of low versus high intensity physical exercise during chemotherapy on physical fitness, fatigue and chemotherapy completion rates: Results of a randomized, controlled trial

van Waart, H., Stuiver, M. M., Sonke, G. S., van Harten, W. H. & Aaronson, N. K., 2014, In : Quality of life research. 23, 1, supplement, 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

PCN170 – Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Miquel Cases, A., Retèl, V. P., van Harten, W. H. & Steuten, L. M. G., 2014, In : Value in health. 17, 7, p. A644-A644

Research output: Contribution to journalMeeting AbstractOther research output

7 Downloads (Pure)

PCN214 – Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

Retèl, V. P., Joosten, S. E. P. & van Harten, W. H., 2014, In : Value in health. 17, 7, p. A652-A652

Research output: Contribution to journalMeeting AbstractOther research output

8 Downloads (Pure)

PCN59 – Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

Mewes, J. C., Steuten, L. M. G., de Boer, A., Frings-Dresen, M. H., IJzerman, M. J. & van Harten, W. H., 2014, In : Value in health. 17, 7, p. A624-A624 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

10 Downloads (Pure)
2013

An interactive web portal for patient empowerment in cancer survivorship

Kuijpers, W., Groen, W. G., Oldenburg, H. S. A., Wouters, M. W. J. M., Aaronson, N. K. & van Harten, W. H., 2013, In : European journal of cancer. 49, s2, p. s255-s256 1202.

Research output: Contribution to journalMeeting AbstractAcademic

Combining 18F-FDG PET/CT and MRI in monitoring neoadjuvant chemotherapy in brest cancer: scenarios and decision modeling to inform development decisions in an early stage

Miquel Cases, A., Steuten, L. M. G., Gilhuijs, K. G. A., Retèl, V. P. & van Harten, W. H., 2013, In : European journal of cancer. Supplement. 49, Suppl. 2, p. S332-S332 1 p., 1518.

Research output: Contribution to journalMeeting AbstractOther research output

Comparing the 70-gene signature to the Dutch Breast Cancer guidelines in the prospective RASTER study

Drukker, C. A., Bueno-de-Mesquita, J. M., Retel, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., van ‘t Veer, L. J., Rutgers, E. J. T., van de Vijver, M. J. & Linn, S. C., 2013, In : European journal of cancer. 49, S2, p. S402-S403 1861.

Research output: Contribution to journalMeeting AbstractAcademic

Large-scale fast-track diagnostics in a comprehensive cancer center

Heintzbergen, S., van Harten, W. H., Goedbloed, N., van Wijngaarden, M., Dernison, A. & Boekhout, A. H., 1 Nov 2013, In : Journal of clinical oncology. 31, 31, S, 185.

Research output: Contribution to journalMeeting AbstractAcademic

PRM97 – Evaluating the cost-effectiveness of multicomponent rehabilitation guidelines

Mewes, J., Steuten, L. M. G., IJzerman, M. J. & van Harten, W. H., 2013, In : Value in health. 16, 3, PA30.

Research output: Contribution to journalMeeting AbstractAcademic

22 Downloads (Pure)
2012

70-Gene Signature Prospectively Predicts Prognosis of Patients with Node-negative Breast Cancer: 5 Year Follow-up of the RASTER Study

Linn, S. C., Drukker, C. A., Retel, V. P., Bueno-de-Mesquita, J. M., van Harten, W. H., van Tinteren, H., Wesseling, J., van ‘t Veer, L. J., Rutgers, E. J. T. & van de Vijver, M. J., 2012, In : European journal of cancer. 48, s1, p. S104 207.

Research output: Contribution to journalMeeting AbstractAcademic

2010

Cost-effectiveness and budget impact of the 70-gene signature for node-negative breast cancer

Retel, V. P., Joore, M. A., Knauer, M., Linn, S. C., Hauptmann, M. & van Harten, W. H., 2010, In : European journal of cancer. Supplement. 8, 3, p. 214 529.

Research output: Contribution to journalMeeting AbstractAcademic